These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 30699887)
1. Proof of an Outer Membrane Target of the Efflux Inhibitor Phe-Arg-β-Naphthylamide from Random Mutagenesis. Schuster S; Bohnert JA; Vavra M; Rossen JW; Kern WV Molecules; 2019 Jan; 24(3):. PubMed ID: 30699887 [TBL] [Abstract][Full Text] [Related]
2. Random mutagenesis of the multidrug transporter AcrB from Escherichia coli for identification of putative target residues of efflux pump inhibitors. Schuster S; Kohler S; Buck A; Dambacher C; König A; Bohnert JA; Kern WV Antimicrob Agents Chemother; 2014 Nov; 58(11):6870-8. PubMed ID: 25182653 [TBL] [Abstract][Full Text] [Related]
3. Aminoacyl β-naphthylamides as substrates and modulators of AcrB multidrug efflux pump. Kinana AD; Vargiu AV; May T; Nikaido H Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1405-10. PubMed ID: 26787896 [TBL] [Abstract][Full Text] [Related]
4. Boosting the Antibacterial Activity of Azithromycin on Multidrug-Resistant Al-Marzooq F; Ghazawi A; Daoud L; Tariq S Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240007 [TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of the inhibition of the drug efflux protein AcrB using surface plasmon resonance. Mowla R; Wang Y; Ma S; Venter H Biochim Biophys Acta Biomembr; 2018 Apr; 1860(4):878-886. PubMed ID: 28890187 [TBL] [Abstract][Full Text] [Related]
6. Phytochemicals increase the antibacterial activity of antibiotics by acting on a drug efflux pump. Ohene-Agyei T; Mowla R; Rahman T; Venter H Microbiologyopen; 2014 Dec; 3(6):885-96. PubMed ID: 25224951 [TBL] [Abstract][Full Text] [Related]
7. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF). Bohnert JA; Schuster S; Fähnrich E; Trittler R; Kern WV J Antimicrob Chemother; 2007 Jun; 59(6):1216-22. PubMed ID: 17062614 [TBL] [Abstract][Full Text] [Related]
8. Comparative reassessment of AcrB efflux inhibitors reveals differential impact of specific pump mutations on the activity of potent compounds. Schuster S; Vavra M; Wirth DAN; Kern WV Microbiol Spectr; 2024 Feb; 12(2):e0304523. PubMed ID: 38170977 [TBL] [Abstract][Full Text] [Related]
9. Importance of Real-Time Assays To Distinguish Multidrug Efflux Pump-Inhibiting and Outer Membrane-Destabilizing Activities in Escherichia coli. Misra R; Morrison KD; Cho HJ; Khuu T J Bacteriol; 2015 Aug; 197(15):2479-88. PubMed ID: 25962916 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of a series of 2-napthamide derivatives as inhibitors of the drug efflux pump AcrB for the reversal of antimicrobial resistance. Wang Y; Mowla R; Guo L; Ogunniyi AD; Rahman T; De Barros Lopes MA; Ma S; Venter H Bioorg Med Chem Lett; 2017 Feb; 27(4):733-739. PubMed ID: 28129976 [TBL] [Abstract][Full Text] [Related]
12. Reversal of the Drug Binding Pocket Defects of the AcrB Multidrug Efflux Pump Protein of Escherichia coli. Soparkar K; Kinana AD; Weeks JW; Morrison KD; Nikaido H; Misra R J Bacteriol; 2015 Oct; 197(20):3255-64. PubMed ID: 26240069 [TBL] [Abstract][Full Text] [Related]
13. Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives. Sjuts H; Vargiu AV; Kwasny SM; Nguyen ST; Kim HS; Ding X; Ornik AR; Ruggerone P; Bowlin TL; Nikaido H; Pos KM; Opperman TJ Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3509-14. PubMed ID: 26976576 [TBL] [Abstract][Full Text] [Related]
14. Some ligands enhance the efflux of other ligands by the Escherichia coli multidrug pump AcrB. Kinana AD; Vargiu AV; Nikaido H Biochemistry; 2013 Nov; 52(46):8342-51. PubMed ID: 24205856 [TBL] [Abstract][Full Text] [Related]
15. Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity. van der Ley P; Steeghs L; Hamstra HJ; ten Hove J; Zomer B; van Alphen L Infect Immun; 2001 Oct; 69(10):5981-90. PubMed ID: 11553534 [TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism of MBX2319 inhibition of Escherichia coli AcrB multidrug efflux pump and comparison with other inhibitors. Vargiu AV; Ruggerone P; Opperman TJ; Nguyen ST; Nikaido H Antimicrob Agents Chemother; 2014 Oct; 58(10):6224-34. PubMed ID: 25114133 [TBL] [Abstract][Full Text] [Related]
17. Fitness and molecular mechanisms of resistance to rifaximin in in vitro selected Escherichia coli mutants. Pons MJ; Mensa L; Gascón J; Ruiz J Microb Drug Resist; 2012 Aug; 18(4):376-9. PubMed ID: 21711150 [TBL] [Abstract][Full Text] [Related]
18. Resistance in Escherichia coli: variable contribution of efflux pumps with respect to different fluoroquinolones. Huguet A; Pensec J; Soumet C J Appl Microbiol; 2013 May; 114(5):1294-9. PubMed ID: 23414263 [TBL] [Abstract][Full Text] [Related]
19. A triple mutant of Escherichia coli lacking secondary acyl chains on lipid A. Vorachek-Warren MK; Ramirez S; Cotter RJ; Raetz CR J Biol Chem; 2002 Apr; 277(16):14194-205. PubMed ID: 11830595 [TBL] [Abstract][Full Text] [Related]